Peter Robert Rose

Person

Ledyard, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Pyrrolo[2,3-d]pyrimidine tosylate salt, crystalline form thereof an...
- Patent number 12,116,368
- Issue date Oct 15, 2024
- Pfizer Inc.
- Brian Matthew Samas
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline form of lorlatinib free base hydrate
- Patent number 11,299,500
- Issue date Apr 12, 2022
- Pfizer Inc.
- Paul Bowles
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for forming amorphous atorvastatin
- Patent number 9,056,831
- Issue date Jun 16, 2015
- Pfizer Inc.
- Antone John deBettencourt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Process for forming amorphous atorvastatin
- Patent number 8,258,315
- Issue date Sep 4, 2012
- Pfizer Inc.
- Antone J deBettencourt, III
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylet...
- Patent number 8,026,376
- Issue date Sep 27, 2011
- Pfizer, Inc.
- Joseph F. Krzyzaniak
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for the preparation of 1,3-substituted indenes
- Patent number 7,285,686
- Issue date Oct 23, 2007
- Pfizer Inc.
- Robert Eugene Handfield, Jr.
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04.9]-hexade...
- Patent number 7,265,119
- Issue date Sep 4, 2007
- Pfizer Inc.
- David E. Bogle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexade...
- Patent number 6,890,927
- Issue date May 10, 2005
- Pfizer Inc.
- David E. Bogle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Citrate salt of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9&#...
- Patent number 6,787,549
- Issue date Sep 7, 2004
- Pfizer Inc.
- Phillip J. Johnson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Processes and intermediates for preparing glycogen phosphorylase in...
- Patent number 6,696,574
- Issue date Feb 24, 2004
- Pfizer Inc.
- Mark T. Barrila
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-(indole-2-carbonyl)-b-alaninamide crystal forms
- Patent number 6,683,106
- Issue date Jan 27, 2004
- Pfizer Inc.
- Douglas J. M. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparing growth hormone secretagogues
- Patent number 6,673,929
- Issue date Jan 6, 2004
- Pfizer Inc.
- Frank R. Busch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Preparation of anhydrous CETP inhibitor
- Patent number 6,573,383
- Issue date Jun 3, 2003
- Pfizer Inc.
- Peter R. Rose
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparing growth hormone secretagogues
- Patent number 6,541,634
- Issue date Apr 1, 2003
- Pfizer Inc.
- Frank R. Busch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polymorphs of a crystalline azo-bicyclo (2.2.2) oct-3-yl amine citr...
- Patent number 6,387,925
- Issue date May 14, 2002
- Pfizer Inc.
- George Joseph Quallich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparing trovafloxacin acid salts
- Patent number 6,359,137
- Issue date Mar 19, 2002
- Pfizer Inc.
- Timothy Norris
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of purifying carbazole ester precursors of 6-chloro-.alpha.-...
- Patent number 6,013,808
- Issue date Jan 11, 2000
- Pfizer Inc.
- Philip D. Hammen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process and intermediates for preparing naphthyridonecarboxylic aci...
- Patent number 5,929,240
- Issue date Jul 27, 1999
- Pfizer Inc.
- Tamim F. Braish
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
PYRROLO[2,3-D]PYRIMIDINE TOSYLATE SALT, CRYSTALLINE FORM THEREOF AN...
- Publication number 20210387989
- Publication date Dec 16, 2021
- Pfizer Inc.
- Brian Matthew SAMAS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORM OF LORLATINIB FREE BASE HYDRATE
- Publication number 20200308191
- Publication date Oct 1, 2020
- Pfizer Inc.
- Paul Bowles
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel Forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy...
- Publication number 20180009748
- Publication date Jan 11, 2018
- WARNER LAMBERT COMPANY LLC
- Joseph Francis Krzyzaniak
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel Forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy...
- Publication number 20170022156
- Publication date Jan 26, 2017
- WARNER LAMBERT COMPANY LLC
- Joseph Francis Krzyzaniak
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel Forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy...
- Publication number 20160046575
- Publication date Feb 18, 2016
- WARNER LAMBERT COMPANY LLC
- Joseph Francis Krzyzaniak
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel Forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy...
- Publication number 20150045563
- Publication date Feb 12, 2015
- WARNER LAMBERT COMPANY LLC
- Joseph Francis Krzyzaniak
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Process for Forming Amorphous Atorvastatin
- Publication number 20140155627
- Publication date Jun 5, 2014
- Pfizer Inc.
- Antone John deBettencourt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel Forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy...
- Publication number 20140018546
- Publication date Jan 16, 2014
- WARNER LAMBERT COMPANY LLC
- Joseph Francis Krzyzaniak
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Process for Forming Amorphous Atorvastatin
- Publication number 20120289576
- Publication date Nov 15, 2012
- Pfizer Inc.
- Antone J. deBettencourt, III
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta,delta-Dihydroxy-...
- Publication number 20110301358
- Publication date Dec 8, 2011
- Pfizer Inc.
- Joseph F. Krzyzaniak
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Process for Forming Amorphous Atorvastatin
- Publication number 20110237642
- Publication date Sep 29, 2011
- Pfizer Inc.
- Antone J. deBettencourt, III
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel Forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta,Delta-Dihydroxy-...
- Publication number 20080306282
- Publication date Dec 11, 2008
- Joseph F. Krzyzaniak
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Process for Forming Amorphous Atorvastatin
- Publication number 20080269314
- Publication date Oct 30, 2008
- Antone John Debetten-Court
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Process for Forming Amorphous Atorvastatin
- Publication number 20070225353
- Publication date Sep 27, 2007
- Pfizer, Inc.
- Jason Albert Leonard
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Complexes of E-2-Methoxy-N-(3-{4-[3-methyl-4-(6-methyl-pyridin-3-yl...
- Publication number 20050272752
- Publication date Dec 8, 2005
- Pfizer Inc.
- Phillip James Johnson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Tartrate salts of 5,8,14-triazatetracyclo [10.3.1.02,11.04,9]-hexad...
- Publication number 20050148591
- Publication date Jul 7, 2005
- Pfizer Inc.
- David E. Bogle
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Process for the preparation of 1,3-substituted indenes
- Publication number 20050004379
- Publication date Jan 6, 2005
- Pfizer Inc.
- Robert Eugene Handfield
- C07 - ORGANIC CHEMISTRY
Information Patent Application
N-(indole-2-carbonyl)-b-alaninamide crystal forms
- Publication number 20040152758
- Publication date Aug 5, 2004
- Pfizer Inc.
- Douglas J. M. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Recipe recorder for automated chemistry
- Publication number 20030222905
- Publication date Dec 4, 2003
- Argonaut Technologies, Inc.
- Craig R. Wierenga
- G05 - CONTROLLING REGULATING
Information Patent Application
N-(indole-2-carbonyl)-b-alaninamide crystal forms
- Publication number 20030195243
- Publication date Oct 16, 2003
- Pfizer Inc.
- Douglas J. M. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Processes and intermediates for preparing glycogen phosphorylase in...
- Publication number 20030187051
- Publication date Oct 2, 2003
- Pfizer Inc.
- Mark T. Barrila
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexade...
- Publication number 20030166701
- Publication date Sep 4, 2003
- Pfizer Inc.
- David E. Bogle
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Intermediates and processes for preparing substituted chromanol der...
- Publication number 20030158428
- Publication date Aug 21, 2003
- Pfizer Inc.
- Keith M. Devries
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Process for preparing growth hormone secretagogues
- Publication number 20030158414
- Publication date Aug 21, 2003
- Frank R Busch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Citrate salt of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca...
- Publication number 20030149091
- Publication date Aug 7, 2003
- Phillip J. Johnson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PREPARATION OF ANHYDROUS CETP INHIBITOR
- Publication number 20030065010
- Publication date Apr 3, 2003
- Peter R. Rose
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Process for preparing growth hormone secretagogues
- Publication number 20020002283
- Publication date Jan 3, 2002
- Frank R Busch
- C07 - ORGANIC CHEMISTRY

Peter Robert Rose

Person

Patents Grantslast 30 patents

Pyrrolo[2,3-d]pyrimidine tosylate salt, crystalline form thereof an...

Crystalline form of lorlatinib free base hydrate

Process for forming amorphous atorvastatin

Process for forming amorphous atorvastatin

Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylet...

Process for the preparation of 1,3-substituted indenes

Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04.9]-hexade...

Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexade...

Citrate salt of 5,8,14-triazatetracyclo&#x0005B;10.3.1.02,11.04,9&#...

Processes and intermediates for preparing glycogen phosphorylase in...

N-(indole-2-carbonyl)-b-alaninamide crystal forms

Process for preparing growth hormone secretagogues

Preparation of anhydrous CETP inhibitor

Process for preparing growth hormone secretagogues

Polymorphs of a crystalline azo-bicyclo (2.2.2) oct-3-yl amine citr...

Process for preparing trovafloxacin acid salts

Method of purifying carbazole ester precursors of 6-chloro-.alpha.-...

Process and intermediates for preparing naphthyridonecarboxylic aci...

Patents Applicationslast 30 patents

PYRROLO[2,3-D]PYRIMIDINE TOSYLATE SALT, CRYSTALLINE FORM THEREOF AN...

CRYSTALLINE FORM OF LORLATINIB FREE BASE HYDRATE

Novel Forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy...

Novel Forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy...

Novel Forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy...

Novel Forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy...

Process for Forming Amorphous Atorvastatin

Novel Forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy...

Process for Forming Amorphous Atorvastatin

Novel Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta,delta-Dihydroxy-...

Process for Forming Amorphous Atorvastatin

Novel Forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta,Delta-Dihydroxy-...

Process for Forming Amorphous Atorvastatin

Process for Forming Amorphous Atorvastatin

Complexes of E-2-Methoxy-N-(3-{4-[3-methyl-4-(6-methyl-pyridin-3-yl...

Tartrate salts of 5,8,14-triazatetracyclo [10.3.1.02,11.04,9]-hexad...

Process for the preparation of 1,3-substituted indenes

N-(indole-2-carbonyl)-b-alaninamide crystal forms

Recipe recorder for automated chemistry

N-(indole-2-carbonyl)-b-alaninamide crystal forms

Processes and intermediates for preparing glycogen phosphorylase in...

Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexade...

Intermediates and processes for preparing substituted chromanol der...

Process for preparing growth hormone secretagogues

Citrate salt of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca...

PREPARATION OF ANHYDROUS CETP INHIBITOR

Process for preparing growth hormone secretagogues

Forms of [R-(R,R)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylet...

Citrate salt of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9&#...

Novel Forms of [R-(R,R)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy...

Novel Forms of [R-(R,R)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy...

Novel Forms of [R-(R,R)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy...

Novel Forms of [R-(R,R)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy...

Novel Forms of [R-(R,R)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy...

Novel Forms of [R-(R,R)]-2-(4-fluorophenyl)-beta,delta-Dihydroxy-...

Novel Forms of [R-(R,R)]-2-(4-Fluorophenyl)-Beta,Delta-Dihydroxy-...